Europe Corneal Transplant Market
Размер рынка в млрд долларов США
CAGR :
% 
 Прогнозируемый период |
2024 –2031 |
 Размер рынка (базовый год) |
USD 100.54 Million |
 Размер рынка (прогнозируемый год) |
USD 155.95 Million |
 CAGR |
% |
| Основные игроки рынка |
Europe Corneal Transplant Market, By Procedure Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Anterior Lamellar Keratoplasty (ALK), Corneal Limbal Stem Cell Transplant, Artifical Cornea Transplant, and Others), Type (Human Cornea and Synthetic), Donor Type (Autograft and Allograft), Graft Type (Partial Thickness Grafts (Lamellar) and Full Thickness Grafts (Penetrating)), Surgery Type (Conventional Surgery, Laser-Assisted Surgery), Indication (Fuch's Endothelial Dystrophy, Infectious Keratitis, Bullous Keratopathy, Keratoconus, Regraft Procedures, Corneal Scarring, Corneal Ulcers, and Others), Gender (Female and Male), Age Group (Geriatric, Adult, and Pediatric), End User (Hospitals, Eye Clinics, Ambulatory Surgical Centers, Academic & Research Institutes, and Others) - Industry Trends and Forecast to 2031
Europe Corneal Transplant Market Analysis and Size
The Europe corneal implants market is driven by several factors, including the increasing prevalence of corneal diseases, a growing aging population, advances in technology, increasing demand for minimally invasive procedures, rising awareness of corneal transplantation, government initiatives and funding, increasing adoption of hybrid and toric lenses, growing popularity of cross-linking procedures, expanding indications for corneal implants, and a competitive landscape that fosters innovation. These factors are collectively driving the demand for corneal implants, particularly in developed countries, as patients seek effective treatments for vision disorders and conditions such as keratoconus, Fuchs' dystrophy, and pseudophakic bullous keratopathy.
Data Bridge Market Research analyzes that the Europe corneal transplant market is expected to reach USD 155.95 million by 2031 from USD 100.54 million in 2023, growing with a CAGR of 5.7% in the forecast period of 2024 to 2031.
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable 2016-2021) |
|
Quantitative Units |
Revenue in USD Million |
|
Segments Covered |
Procedure Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Anterior Lamellar Keratoplasty (ALK), Corneal Limbal Stem Cell Transplant, Artifical Cornea Transplant, and Others), Type (Human Cornea and Synthetic), Donor Type (Autograft and Allograft), Graft Type (Partial Thickness Grafts (Lamellar) and Full Thickness Grafts (Penetrating)), Surgery Type (Conventional Surgery, Laser-Assisted Surgery), Indication (Fuch's Endothelial Dystrophy, Infectious Keratitis, Bullous Keratopathy, Keratoconus, Regraft Procedures, Corneal Scarring, Corneal Ulcers, and Others), Gender (Female and Male), Age Group (Geriatric, Adult, and Pediatric), End User (Hospitals, Eye Clinics, Ambulatory Surgical Centers, Academic & Research Institutes, and Others) |
|
Countries Covered |
Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Denmark, Norway, Sweden, Poland, Rest of Europe |
|
Market Players Covered |
ZEISS Group (Carl Zeiss Meditec AG.), Alcon, CorneaGen, Ziemer Ophthalmic Systems AG, RUMEX International Co., among others. |
Market Definition
The corneal transplant market refers to the medical field focused on surgical procedures that replace damaged or diseased corneas with healthy donor tissue. Corneal transplants, also known as keratoplasty, are performed to restore vision in patients suffering from conditions such as keratoconus, corneal scarring, infections, or corneal endothelial dysfunction. The market encompasses various types of transplant procedures, including penetrating keratoplasty (full-thickness corneal transplant) and endothelial keratoplasty (partial-thickness transplant), and is supported by advancements in surgical techniques, availability of donor tissues, and improved postoperative care. As eye disorders become more prevalent globally, and with technological innovations enhancing the success rate of surgeries, the corneal transplant market continues to grow, addressing the rising demand for vision restoration.
Europe Corneal Transplant Market Dynamics:
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:
Drivers
- Increasing Prevalence of Eye Diseases
The increasing prevalence of eye diseases is a significant driver in the Europe corneal transplant market, as conditions like keratoconus, Fuchs' endothelial dystrophy, and corneal scarring due to infections or trauma are becoming more common. These diseases can lead to severe vision impairment or blindness, prompting a growing demand for corneal transplants as a restorative treatment. The rise in eye disorders is often linked to factors such as aging populations, higher rates of diabetes, and increased exposure to environmental pollutants and UV radiation, which can damage the cornea. Also, advancements in diagnostic techniques are leading to earlier detection of these diseases, allowing for timely interventions, including corneal transplantation. Furthermore, greater awareness of corneal health and the availability of improved surgical techniques, such as Descemet's Membrane Endothelial Keratoplasty (DMEK) and Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK), are contributing to the growing acceptance of corneal transplants. As the burden of eye diseases continues to grow worldwide, the need for effective solutions like corneal transplants is expected to rise, fueling market growth.
For instance,
- In June 2023, according to the article published in NCBI, a study was conducted to investigate the prevalence of keratoconus in a large German cohort and to evaluate possible associated factors. Keratoconus appears to be a rare corneal disease with a prevalence previously estimated at 1:2000. However, in recent relatively small studies, a higher prevalence was found. Prevalence is reported from 1: 6000 for US citizens, 1:1000 for Israeli adolescents, up to 1:20 for Saudi-Arabian Children. Newer studies detected prevalence estimates of 1:191 in New Zealand high school students. A prevalence of up to 1:84 was detected for young Australian adults. The prevalence of keratoconus treatment in the German population is approximately tenfold higher than previously reported in the literature using the latest technologies, namely Scheimpflug imaging, which act as a driver in the growth of the market.
Rising Geriatric Population
The rising geriatric population is a key driver in the Europe corneal transplant market, as older adults are more susceptible to various eye conditions that can lead to corneal damage and the need for transplants. Age-related eye diseases, such as Fuchs' endothelial dystrophy, bullous keratopathy, and other degenerative corneal disorders, become more prevalent with advancing age, significantly increasing the demand for corneal transplants. Also, older adults are more likely to experience complications from cataract surgery or develop chronic conditions like diabetes, which can further contribute to corneal deterioration. As the Europe population ages, the number of individuals requiring corneal transplants is expected to rise, particularly in regions with rapidly aging demographics. This trend is further fueled by increased awareness about the availability and success rates of corneal transplants, as well as advancements in surgical techniques that offer better outcomes and faster recovery times for older patients. As a result, the growing geriatric population is a major factor driving the expansion of the Europe corneal transplant market, highlighting the need for accessible and effective treatment options for age-related corneal diseases.
Opportunity
- Rise in Healthcare Infrastructure
The rise in healthcare infrastructure offers significant opportunities for the Europe corneal transplant market by expanding access to transplant services. Enhanced infrastructure leads to the establishment of more hospitals and specialized clinics, making corneal transplants more accessible to a broader population. Improved facilities in underserved or rural areas ensure that patients who previously had limited access to specialized eye care can now receive essential transplant services.
Modernized healthcare facilities are equipped with advanced surgical technologies and diagnostic tools, which directly improve the success rates of corneal transplants and minimize complications. Specialized centers within these advanced systems provide focused expertise and resources, further enhancing surgical outcomes and patient care. The increased capacity of these facilities also supports a higher volume of transplant procedures, effectively addressing patient demand and reducing waiting times.
For instance,
- In April 2024, according to the article ‘The Rise of Hospital Infrastructure & Modernization Updates,’ the U.S. boasts of a robust healthcare infrastructure consisting of over 6,000 hospitals and thousands of small clinics, offering more than a million hospital beds to patients. This infrastructure encompasses a variety of essential elements, such as advanced research labs, cutting-edge technology, and a wide range of medical equipment. Moreover, the federal government has been providing funds for the continuous modernization of the country’s healthcare infrastructure
- In August 2023, according to JLL India, India has been welcoming more investments and innovation to deal with future life-threatening diseases and pandemics that, in turn, help in growing the country’s healthcare and life sciences sector
Restraint/Challenge
- The High Cost of Corneal Transplant Surgery
The high cost of corneal transplant surgery acts as a significant restraint on the growth of the Europe corneal transplant market by limiting patient access and affordability, particularly in low- and middle-income countries. Corneal transplant procedures, including traditional Penetrating Keratoplasty (PK) and advanced techniques like Descemet’s Membrane Endothelial Keratoplasty (DMEK) or Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK), often involve substantial expenses not only for the surgical procedure itself but also for the associated costs of preoperative assessments, postoperative care, medications, and follow-up visits. Also, the cost of obtaining donor corneas, whether through eye banks or commercial sources, further contributes to the financial burden. In many regions, particularly those with limited healthcare infrastructure, these costs are exacerbated by a lack of insurance coverage or inadequate reimbursement policies, making corneal transplants financially inaccessible to a large portion of the population. Furthermore, the need for specialized surgical expertise and advanced equipment increases the overall expense, thereby restricting the availability of these procedures to well-equipped medical centers in urban areas. Consequently, the high costs associated with corneal transplant surgery hinder market growth by reducing the potential patient pool, especially in underserved regions where the burden of corneal diseases is often most significant and access to affordable healthcare is limited.
Recent Developments
- In January 2024, Carl Zeiss India's Medical Technology Division showcased Cataract and Refractive Workflow at Phaco Festival by Nethradhama Super Speciality, Bengaluru. At the Phaco Festival, the spotlight shined on ZEISS's transformative impact on the Cataract and Corneal Refractive Workflows.
- In June 2024, CorneaGen today announces the commercial launch of Corneal Tissue Addition for Keratoplasty (CTAK), an innovative and extremely effective solution to corneal contouring for keratoconic eyes. Developed by CorneaGen in partnership with CTAK LLC and Ziemer, CTAK provides patient ready, gamma-irradiated sterile, non-immunogenic corneal tissue segments, laser cut and customized to patients’ specific cone severity and location
- In January 2024, Seattle-based CorneaGen is excited to announce an expansion of their eye recovery services throughout northern and southern California. Through this expansion of service, CorneaGen will now provide both eye recovery and processing services of donor tissue for facilities throughout the state, resulting in an even better experience for the patients, families, and staff of their California partner facilities.
- In August 2024, ZEISS extends its global refractive industry momentum with more than 10 million eyes treated with ZEISS SMILE and ZEISS SMILE pro; ZEISS announces first treatment in the CE market for hyperopia with lenticule extraction using ZEISS SMILE pro technology
Europe Corneal Transplant Market Scope
The Europe corneal transplant market is segmented into eight notable segments based on procedure type, type, donor type, graft type, surgery type, indication, gender, age group, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Procedure Type
- Endothelial Keratoplasty
- Penetrating Keratoplasty
- Anterior Lamellar Keratoplasty (ALK)
- Corneal Limbal Stem Cell Transplant
- Artifical Cornea Transplant
- Others
On the basis of procedure type, the market is segmented into endothelial keratoplasty, penetrating keratoplasty, Anterior Lamellar Keratoplasty (ALK), corneal limbal stem cell transplant, artifical cornea transplant and others.
Type
- Human Cornea
- Synthetic
On the basis of type, the market is segmented into human cornea and synthetic.
Donor Type
- Allograft
- Autograft
On the basis of donor type, the market is segmented into allograft and autograft.
Graft Type
- Partial Thickness Grafts (Lamellar)
- Full Thickness Grafts (Penetrating)
On the basis of graft type, the market is segmented into partial thickness grafts (lamellar), full thickness grafts (penetrating).
Surgery Type
- Conventional Surgery
- Laser-Assisted Surgery
On the basis of surgery type, the market is segmented into conventional surgery and laser-assisted surgery.
Indication
- Fuch's Endothelial Dystrophy
- Infectious Keratitis
- Bullous Keratopathy
- Keratoconus
- Regraft Procedures
- Corneal Scarring
- Corneal Ulcers
- Others
On the basis of indication, the market is segmented into fuch's endothelial dystrophy, infectious keratitis, bullous keratopathy, keratoconus, regraft procedures, corneal scarring, corneal ulcers and others.
Gender
- Female
- Male
On the basis of gender, the market is segmented into female and male.
Age Group
- Geriatric
- Adult
- Pediatric
On the basis of age group, the market is segmented into geriatric, adult and pediatric.
End User
- Hospitals,
- Eye Clinics,
- Ambulatory Surgical Centers,
- Academic & Research Institutes
- Others
On the basis of end user, the market is segmented into hospitals, eye clinics, ambulatory surgical centers, academic & research institutes and others.
Europe Corneal Transplant Market Regional Analysis/Insights
Europe corneal transplant market is analyzed, and market size insights and trends are provided based on procedure type, type, donor type, graft type, surgery type, indication, gender, age group, and end user as referenced above.
The countries covered in this market report are Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Denmark, Norway, Sweden, Poland, Rest of Europe,
Germany is expected to dominate in the Europe market due to its advanced healthcare infrastructure, significant consumer demand for eye treatments, strong pharmaceutical industry, extensive research and development efforts, and well-established distribution networks, making it a hub for innovation.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe Corneal Transplant Market Share Analysis
The Europe corneal transplant market is segmented into eight notable segments based on procedure type, donor type, graft type, surgery type, indication, gender, age group, and end user.
The Europe corneal transplant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the Europe corneal transplant market.
Some of the major players operating in the the Europe corneal transplant market are ZEISS Group (Carl Zeiss Meditec AG.), Alcon, CorneaGen, Ziemer Ophthalmic Systems AG, RUMEX International Co., among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE CORNEAL IMPLANTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 EUROPE CORNEAL TRANSPLANT MARKET: REGULATIONS
5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION
5.2 NORTH AMERICA REGULATORY SCENARIO
5.3 EUROPE REGULATORY SCENARIO
5.4 MIDDLE EAST AND AFRICA REGULATORY SCENARIO
5.5 SOUTH AMERICA REGULATORY SCENARIO
6 CUSTOMIZATION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF EYE DISEASES
7.1.2 RISING GERIATRIC POPULATION
7.1.3 TECHNOLOGICAL ADVANCEMENTS IN CORNEAL IMPLANTS
7.1.4 RISE IN MINIMALLY INVASIVE SURGERY IN CORNEAL TRANSPLANT
7.2 RESTRAINTS
7.2.1 HIGH COST ASSOCIATED WITH CORNEAL TRANSPLANT SURGERY
7.2.2 SHORTAGE OF DONORS IN CORNEAL TRANSPLANT
7.3 OPPORTUNITIES
7.3.1 RISE IN HEALTHCARE INFRASTRUCTURE
7.3.2 INCREASE IN PUBLIC AWARENESS AND EDUCATION
7.3.3 PARTNERSHIPS AND COLLABORATIONS ASSOCIATED WITH CORNEAL TRANSPLANTS
7.4 CHALLENGES
7.4.1 SURGICAL AND POST-SURGICAL COMPLICATIONS
7.4.2 LIMITED AWARENESS AND TRAINING
8 EUROPE CORNEAL TRANSPLANT MARKET, BY TYPE
8.1 OVERVIEW
8.2 HUMAN CORNEA
8.3 SYNTHETIC
9 EUROPE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE
9.1 OVERVIEW
9.2 ENDOTHELIAL KERATOPLASTY
9.2.1 DESCEMET'S MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK)
9.2.2 DESCEMET'S STRIPPING ENDOTHELIAL KERATOPLASTY(DSEK)/DESCEMET'S STRIPPING AUTOMATED ENDOTHELIAL KERATOPLASTY (DSAEK)
9.3 PENETRATING KERATOPLASTY
9.4 ANTERIOR LAMELLAR KERATOPLASTY (ALK)
9.4.1 DEEP ANTERIOR LAMELLAR KERATOPLASTY (DALK)
9.4.2 SUPERFICIAL ANTERIOR LAMELLAR KERATOPLASTY (SALK)
9.5 CORNEAL LIMBAL STEM CELL TRANSPLANT
9.6 ARTIFICIAL CORNEA TRANSPLANT
9.7 OTHERS
10 EUROPE CORNEAL TRANSPLANT MARKET, BY DONOR TYPE
10.1 OVERVIEW
10.2 ALLOGRAFT
10.3 AUTOGRAFT
11 EUROPE CORNEAL TRANSPLANT MARKET, BY INDICATION
11.1 OVERVIEW
11.2 FUCH'S ENDOTHELIAL DYSTROPHY
11.3 INFECTIOUS KERATITIS
11.4 BULLOUS KERATOPATHY
11.5 KERATOCONUS
11.6 REGRAFT PROCEDURES
11.7 CORNEAL SCARRING
11.8 CORNEAL ULCERS
11.9 OTHERS
12 EUROPE CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE
12.1 OVERVIEW
12.2 PARTIAL THICKNESS GRAFTS (LAMELLAR)
12.2.1 DEEP LAMELLAR GRAFTS
12.2.2 SUPERFICIAL LAMELLAR GRAFTS
12.3 FULL THICKNESS GRAFTS (PENETRATING)
13 EUROPE CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE
13.1 OVERVIEW
13.2 CONVENTIONAL SURGERY
13.3 LASER-ASSISTED SURGERY
14 EUROPE CORNEAL TRANSPLANT MARKET, BY GENDER
14.1 OVERVIEW
14.2 FEMALE
14.3 MALE
15 EUROPE CORNEAL TRANSPLANT MARKET, BY AGE GROUP
15.1 OVERVIEW
15.2 GERIATRIC
15.3 ADULT
15.4 PEDIATRIC
16 EUROPE CORNEAL TRANSPLANT MARKET, BY END USER
16.1 OVERVIEW
16.2 HOSPITALS
16.3 EYE CLINICS
16.4 AMBULATORY SURGICAL CENTERS
16.5 ACADEMIC & RESEARCH INSTITUTES
16.6 OTHERS
17 EUROPE CORNEAL TRANSPLANT MARKET, BY REGION
17.1 EUROPE
17.1.1 GERMANY
17.1.2 FRANCE
17.1.3 UK
17.1.4 SPAIN
17.1.5 ITALY
17.1.6 RUSSIA
17.1.7 SWITZERLAND
17.1.8 NETHERLANDS
17.1.9 TURKEY
17.1.10 BELGIUM
17.1.11 REST OF EUROPE
18 EUROPE CORNEAL TRANSPLANT MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: EUROPE
19 SWOT ANALYSIS
20 COMPANY PROFILES
20.1 ZEISS GROUP (CARL ZEISS MEDITEC AG.)
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.2 ALCON
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENT
20.3 CORNEAGEN
20.3.1 COMPANY SNAPSHOT
20.3.2 COMPANY SHARE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.4 ZIEMER OPHTHALMIC SYSTEMS AG
20.4.1 COMPANY SNAPSHOT
20.4.2 COMPANY SHARE ANALYSIS
20.4.3 PRODUCT PORTFOLIO
20.4.4 RECENT DEVELOPMENT
20.5 RUMEX INTERNATIONAL CO.
20.5.1 COMPANY SNAPSHOT
20.5.2 COMPANY SHARE ANALYSIS
20.5.3 PRODUCT PORTFOLIO
20.5.4 RECENT DEVELOPMENT
20.6 AJL OPHTHALMIC S.A.
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 CORNEAT VISION
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.8 FLORIDA LIONS EYE BANK
20.8.1 COMPANY SNAPSHOT
20.8.2 PRODUCT PORTFOLIO
20.8.3 RECENT DEVELOPMENT
20.9 KERAMED, INC.
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENT
20.1 MASSACHUSETTS EYE AND EAR
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENT
20.11 OCL VISION
20.11.1 COMPANY SNAPSHOT
20.11.2 SERVICE PORTFOLIO
20.11.3 RECENT DEVELOPMENT
20.12 OVATION INTERNATIONAL
20.12.1 COMPANY SNAPSHOT
20.12.2 PRODUCT PORTFOLIO
20.12.3 RECENT DEVELOPMENT
20.13 SAN DIEGO EYE BANK
20.13.1 COMPANY SNAPSHOT
20.13.2 SERVICE PORTFOLIO
20.13.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
Список таблиц
TABLE 1 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY SURGERY TYPE
TABLE 2 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY INDICATION
TABLE 3 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY AGE
TABLE 4 NUMBER OF PATIENTS WAITING IN EACH COUNTRY
TABLE 5 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY DONOR TYPE
TABLE 6 PERCENTAGE OF HOSPITALS IN EACH COUNTRY WHERE CORNEAL TRANSPLANTS ARE PERFORMED (CLINICS OR HOSPITALS).
TABLE 7 AVERAGE COST FOR THE CORNEAL TRANSPLANT (PER/EYE) WITH RESPECT TO THE PROCEDURE TYPE IN ASIA-PACIFIC (INDIA)
TABLE 8 AVERAGE COST FOR THE CORNEAL TRANSPLANT WITH RESPECT TO THE PROCEDURE TYPE IN EUROPE
TABLE 9 AVERAGE COST FOR THE CORNEAL TRANSPLANT WITH RESPECT TO THE PROCEDURE TYPE IN SOUTH AMERICA
TABLE 10 EUROPE CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 11 EUROPE HUMAN CORNEA IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 12 EUROPE SYNTHETIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 13 EUROPE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 EUROPE ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 15 EUROPE ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 16 EUROPE PENETRATING KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 EUROPE ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 18 EUROPE ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 19 EUROPE CORNEAL LIMBAL STEM CELL TRANSPLANT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 20 EUROPE ARTIFICIAL CORNEA TRANSPLANT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 EUROPE OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 22 EUROPE CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 23 EUROPE ALLOGRAFT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 24 EUROPE ALLOGRAFT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 25 EUROPE CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 26 EUROPE FUCH'S ENDOTHELIAL DYSTROPHY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 27 EUROPE INFECTIOUS KERATITIS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 28 EUROPE BULLOUS KERATOPATHY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 29 EUROPE KERATOCONUS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 30 EUROPE REGRAFT PROCEDURES IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 31 EUROPE CORNEAL SCARRING IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 32 EUROPE CORNEAL ULCERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 33 EUROPE OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 34 EUROPE CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 35 EUROPE PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 36 EUROPE PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 37 EUROPE FULL THICKNESS GRAFTS (PENETRATING) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 38 EUROPE CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 EUROPE CONVENTIONAL SURGERY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 40 EUROPE LASER-ASSISTED SURGERY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 41 EUROPE CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 42 EUROPE FEMALE IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 43 EUROPE MALE IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 44 EUROPE CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 45 EUROPE GERIATRIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 46 EUROPE ADULT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 47 EUROPE PEDIATRIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 48 EUROPE CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 49 EUROPE HOSPITALS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 50 EUROPE EYE CLINICS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 51 EUROPE AMBULATORY SURGICAL CENTERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 52 EUROPE ACADEMIC & RESEARCH INSTITUTES IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 53 EUROPE OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 54 EUROPE CORNEAL TRANSPLANT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 55 EUROPE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 56 EUROPE ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 EUROPE ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 58 EUROPE CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 EUROPE CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 EUROPE CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 61 EUROPE PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 62 EUROPE CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 63 EUROPE CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 64 EUROPE CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 65 EUROPE CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 66 EUROPE CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 67 GERMANY CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 68 GERMANY ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 GERMANY ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 70 GERMANY CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 71 GERMANY CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 72 GERMANY CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 73 GERMANY PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 74 GERMANY CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 75 GERMANY CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 76 GERMANY CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 77 GERMANY CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 78 GERMANY CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 79 FRANCE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 80 FRANCE ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 81 FRANCE ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 82 FRANCE CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 83 FRANCE CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 84 FRANCE CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 85 FRANCE PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 86 FRANCE CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 87 FRANCE CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 88 FRANCE CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 89 FRANCE CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 90 FRANCE CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 91 UK CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 92 UK ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 93 UK ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 94 UK CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 95 UK CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 96 UK CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 97 UK PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 98 UK CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 99 UK CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 100 UK CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 101 UK CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 102 UK CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 103 SPAIN CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 104 SPAIN ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 105 SPAIN ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 106 SPAIN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 107 SPAIN CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 108 SPAIN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 SPAIN PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 110 SPAIN CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 111 SPAIN CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 112 SPAIN CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 113 SPAIN CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 114 SPAIN CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 115 ITALY CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 116 ITALY ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 117 ITALY ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 118 ITALY CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 119 ITALY CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 120 ITALY CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 121 ITALY PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 122 ITALY CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 123 ITALY CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 124 ITALY CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 125 ITALY CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 126 ITALY CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 127 RUSSIA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 128 RUSSIA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 129 RUSSIA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 130 RUSSIA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 131 RUSSIA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 132 RUSSIA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 133 RUSSIA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 134 RUSSIA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 135 RUSSIA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 136 RUSSIA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 137 RUSSIA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 138 RUSSIA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 139 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 140 SWITZERLAND ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 141 SWITZERLAND ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 142 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 143 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 144 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 145 SWITZERLAND PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 146 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 147 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 148 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 149 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 150 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 151 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 152 NETHERLANDS ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 153 NETHERLANDS ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 154 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 155 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 156 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 157 NETHERLANDS PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 158 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 159 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 160 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 161 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 162 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 163 TURKEY CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 164 TURKEY ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 165 TURKEY ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 166 TURKEY CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 167 TURKEY CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 TURKEY CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 169 TURKEY PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 170 TURKEY CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 171 TURKEY CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 172 TURKEY CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 173 TURKEY CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 174 TURKEY CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 175 BELGIUM CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 176 BELGIUM ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 177 BELGIUM ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 178 BELGIUM CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 179 BELGIUM CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 180 BELGIUM CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 181 BELGIUM PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 182 BELGIUM CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 183 BELGIUM CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 184 BELGIUM CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 185 BELGIUM CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 186 BELGIUM CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 187 REST OF EUROPE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
Список рисунков
FIGURE 1 EUROPE CORNEAL TRANSPLANT MARKET: SEGMENTATION
FIGURE 2 EUROPE CORNEAL TRANSPLANT MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE CORNEAL TRANSPLANT MARKET: DROC ANALYSIS
FIGURE 4 EUROPE CORNEAL TRANSPLANT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE CORNEAL TRANSPLANT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE CORNEAL TRANSPLANT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE CORNEAL TRANSPLANT MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 EUROPE CORNEAL TRANSPLANT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE CORNEAL TRANSPLANT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE CORNEAL TRANSPLANT MARKET: SEGMENTATION
FIGURE 11 SIX SEGMENTS COMPRISE THE EUROPE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 INCREASING PREVALENCE OF EYE DISEASES IS DRIVING THE GROWTH OF THE EUROPE CORNEAL TRANSPLANT MARKET FROM 2024 TO 2031
FIGURE 15 THE ENDOTHELIAL KERATOPLASTY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CORNEAL TRANSPLANT MARKET IN 2024 AND 2031
FIGURE 16 DROC ANALYSIS
FIGURE 17 EUROPE CORNEAL TRANSPLANT MARKET: BY TYPE, 2023
FIGURE 18 EUROPE CORNEAL TRANSPLANT MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 19 EUROPE CORNEAL TRANSPLANT MARKET: TYPE, CAGR (2024-2031)
FIGURE 20 EUROPE CORNEAL TRANSPLANT MARKET: TYPE, LIFELINE CURVE
FIGURE 21 EUROPE CORNEAL TRANSPLANT MARKET: BY PROCEDURE TYPE, 2023
FIGURE 22 EUROPE CORNEAL TRANSPLANT MARKET: BY PROCEDURE TYPE, 2024-2031 (USD THOUSAND)
FIGURE 23 EUROPE CORNEAL TRANSPLANT MARKET: PROCEDURE TYPE, CAGR (2024-2031)
FIGURE 24 EUROPE CORNEAL TRANSPLANT MARKET: PROCEDURE TYPE, LIFELINE CURVE
FIGURE 25 EUROPE CORNEAL TRANSPLANT MARKET: BY DONOR TYPE, 2023
FIGURE 26 EUROPE CORNEAL TRANSPLANT MARKET: BY DONOR TYPE, 2024-2031 (USD THOUSAND)
FIGURE 27 EUROPE CORNEAL TRANSPLANT MARKET: DONOR TYPE, CAGR (2024-2031)
FIGURE 28 EUROPE CORNEAL TRANSPLANT MARKET: DONOR TYPE, LIFELINE CURVE
FIGURE 29 EUROPE CORNEAL TRANSPLANT MARKET: BY INDICATION, 2023
FIGURE 30 EUROPE CORNEAL TRANSPLANT MARKET: BY INDICATION, 2024-2031 (USD THOUSAND)
FIGURE 31 EUROPE CORNEAL TRANSPLANT MARKET: BY INDICATION, CAGR (2024-2031)
FIGURE 32 EUROPE CORNEAL TRANSPLANT MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 33 EUROPE CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, 2023
FIGURE 34 EUROPE CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 35 EUROPE CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, CAGR (2024-2031)
FIGURE 36 EUROPE CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, LIFELINE CURVE
FIGURE 37 EUROPE CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, 2023
FIGURE 38 EUROPE CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 39 EUROPE CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, CAGR (2024-2031)
FIGURE 40 EUROPE CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 41 EUROPE CORNEAL TRANSPLANT MARKET: BY GENDER, 2023
FIGURE 42 EUROPE CORNEAL TRANSPLANT MARKET: BY GENDER, 2024-2031 (USD THOUSAND)
FIGURE 43 EUROPE CORNEAL TRANSPLANT MARKET: BY GENDER, CAGR (2024-2031)
FIGURE 44 EUROPE CORNEAL TRANSPLANT MARKET: BY GENDER, LIFELINE CURVE
FIGURE 45 EUROPE CORNEAL TRANSPLANT MARKET: BY AGE GROUP, 2023
FIGURE 46 EUROPE CORNEAL TRANSPLANT MARKET: BY AGE GROUP, 2024-2031 (USD THOUSAND)
FIGURE 47 EUROPE CORNEAL TRANSPLANT MARKET: BY AGE GROUP, CAGR (2024-2031)
FIGURE 48 EUROPE CORNEAL TRANSPLANT MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 49 EUROPE CORNEAL TRANSPLANT MARKET: BY END USER, 2023
FIGURE 50 EUROPE CORNEAL TRANSPLANT MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 51 EUROPE CORNEAL TRANSPLANT MARKET: BY END USER, CAGR (2024-2031)
FIGURE 52 EUROPE CORNEAL TRANSPLANT MARKET: BY END USER, LIFELINE CURVE
FIGURE 53 EUROPE CORNEAL TRANSPLANT MARKET: SNAPSHOT (2023)
FIGURE 54 EUROPE CORNEAL TRANSPLANT MARKET: COMPANY SHARE 2023 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
